Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | CHAT | P28329 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5679481 | 0.87 | RAB9A (0.46) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| SCHEMBL6332742 | 0.83 | RAB9A (0.43) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| SCHEMBL1049804 | 0.82 | MAPT (0.55) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| SCHEMBL30894444 | 0.82 | MAPT (0.55) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| Trifluoromethanesulfonic Acid SCHEMBL7049988 | 0.81 | HTT (0.48) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| SCHEMBL1002271 | 0.81 | KDM4E (0.42) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL6330564 | 0.80 | MAPT (0.58) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| Iodide SCHEMBL336208 | 0.80 | MAPT (0.53) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| Iodide SCHEMBL29462686 | 0.80 | MAPT (0.53) | RAB9ARCE1MAPTHTTSMN1; SMN2 | |
| SCHEMBL11074520 | 0.79 | HTT (0.48) | RAB9ARCE1MAPTHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | claimed |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-05-20 | — | — | US | claimed |
| WO-2018163217-A2 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-09-13 | — | — | WO | claimed |
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | disclosed |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-05-20 | — | — | US | disclosed |
| WO-2018163217-A2 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-09-13 | — | — | WO | disclosed |
| US-20030118916-A1 | Heteroaromatic compounds having two-photon absorption activity | PAGANI GIORGIO (IT) | 2003-06-26 | — | — | US | disclosed |
| EP-1268467-A1 | HETEROAROMATIC COMPOUNDS HAVING TWO-PHOTON ABSORPTION ACTIVITY | Universita' Degli Studi Di Milano - Bicocca (IT) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001070735-A1 | HETEROAROMATIC COMPOUNDS HAVING TWO-PHOTON ABSORPTION ACTIVITY | UNIVERSITA' DEGLI STUDI DI MILANO - BICOCCA (IT) | 2001-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | CBR1, POR, CAT | RAB9A 1579/4885RCE1 918/4885MAPT 4294/4885 |
| US-20030118916-A1 | Heteroaromatic compounds having two-photon absorption activity | NPC1L1, ABCG2, ARNT | RAB9A 3403/4885RCE1 358/4885MAPT 1807/4885 |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | CBR1, POR, CAT | RAB9A 1529/4885RCE1 940/4885MAPT 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.